Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Sassan Farjami"'
Autor:
Alexander J Sweidan, Anthony Leung, Cassandra J Kaiser, Sarah J Strube, Andrei N Dokukin, Stephen Romansky, Sassan Farjami
Publikováno v:
Clinical Medicine Insights: Case Reports, Vol 10 (2017)
A 70-year-old previously independent man developed progressive proximal leg weakness resulting in a fall at home suffering traumatic brain injury. He was prescribed a statin medication two years prior, but this was discontinued on admission to the ho
Externí odkaz:
https://doaj.org/article/a75d73e153f74fa7bdaaac45bccdcc7d
Publikováno v:
World Journal of Oncology
Lung cancer is the number one cause of cancer-related deaths in the United States. Involvement of pericardium occurs once cancer has progressed to stage IV which can cause massive effusion in the pericardial sac. This can lead to cardiac tamponade wh
Publikováno v:
Journal of Medical Cases. 9:309-312
Autor:
Kiran, Yalamanchili, Judy, Lalmuanpuii, Faisal, Waheed, Sassan, Farjami, Ram, Kancherla, Zeeshan, Qureshi, Albert, Hoang, Yusuf, Khaled, Diana, Lake, Carmello, Puccio, Hoo G, Chun, Karen, Seiter, Tauseef, Ahmed
Publikováno v:
Anticancer research. 28(5B)
Despite the advances in breast cancer care, inflammatory breast cancer (IBC) has a poor prognosis. The purpose of this study was to determine the efficacy of high-dose chemotherapy (HDCT) with thiotepa, mitoxantrone and carboplatin (TMJ regimen) in w
Publikováno v:
Journal of Clinical Oncology. 24:10694-10694
10694 Background: Despite the improvements related to introduction of neoadjuvant chemotherapy, the prognosis of patients with inflammatory breast cancer remains poor. The purpose of this study was to evaluate the efficacy, feasibility and outcomes o
Autor:
A. Mittelman, Z Qureshi, R Kancherla, Tauseef Ahmed, Albert Hoang, C. Puccio, Karen Seiter, Sassan Farjami
Publikováno v:
Journal of Clinical Oncology. 23:824-824
824 Background: One of the potential drawbacks of high-dose chemotherapy (HD-CT) in breast cancer is transplant related mortality and long term complications associated with conditioning regimens. ...
Publikováno v:
Blood. 104:4951-4951
Background: A number of randomized and non-randomized studies have demonstrated the efficacy of the high-dose therapy with stem cell rescue. The efficacies of these treatment modalities were mainly related to the degree of myeloablation and destructi